TCL Archive IOM Committee Will Probe Duke Scandal Together With Other “Omics” Case Studies January 7, 2011
TCL Archive Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products. April 22, 2005
TCL Archive Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market August 2, 2002